Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: A review

Neurosurgery

Volumn 56, Issue 4, 2005, Pages 633-652

  Harrod, Christopher G ^a   Bendok, Bernard R ^a   Batjer, H Hunt ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cerebral vasospasm; Markers; Risk factors; Subarachnoid hemorrhage

Indexed keywords

CELL ADHESION MOLECULE; COCAINE; ENDOTHELIN 1; GROWTH FACTOR; LIPID PEROXIDE; MAGNESIUM;

ADULT; AGED; BRAIN ARTERY ANEURYSM; BRAIN VASOSPASM; CLINICAL RESEARCH; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE MARKER; DOCTOR PATIENT RELATION; EVALUATION; FEMALE; GENETIC MARKER; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; PROBLEM SOLVING; REVIEW; RISK FACTOR; SUBARACHNOID HEMORRHAGE;

HUMANS; INCIDENCE; INTRACRANIAL ANEURYSM; RECURRENCE; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 16844373283     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000156644.45384.92     Document Type: Review

References (198)

1. Adams HP Jr, Kassell NF, Torner JC, Haley EC Jr: Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhage: Influences of clinical condition, CT results, and antifibrinolytic therapy - A report of the Cooperative Aneurysm Study. Neurology 37:1586-1591, 1987.
2. Ahmed NA, Yee J, Giannias B, Kapadia B, Christou NV: Expression of human neutrophil L-selectin during the systemic inflammatory response syndrome is partly mediated by tumor factor α. Arch Surg 131:31-35, 1996.
3. Aihara Y, Kasuya H, Onda H, Hori T, Takeda J: Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage. Stroke 32:212-217, 2001.
4. Allcock JM, Drake CG: Ruptured I-C aneurysms: The role of arterial spasm. J Neurosurg 22:21-29, 1965.
5. Aoki T, Takenaka K, Suzuki S, Kassell NF, Sagher O, Lee KS: The role of hemolysate in the facilitation of oxyhemoglobin-induced contraction in rabbit basilar arteries. J Neurosurg 81:261-266, 1994.
6. Asano T, Ikegaki I, Suzuki Y, Satoh S, Shibuya M: Endothelin and the production of cerebral vasospasms in dogs. Biochem Biophys Res Commun 159:1345-1351, 1989.
7. Awad IA, Carter LP, Spetzler RF, Medina M, Williams FC Jr: Clinical vasospasm after subarachnoid hemorrhage: Response to hypervolemic hemodilution and arterial hypertension. Stroke 18:365-372, 1987.
8. Bavbek M, Polin R, Kwan AL, Arthur AS, Kassell NF, Lee KS: Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Stroke 29:1930-1936, 1998.
9. Bendok BR, Getch CC, Malisch TW, Batjer HH: Treatment of aneurysmal subarachnoid hemorrhage. Semin Neurol 18:521-531, 1998.
10. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2:737-744, 2000.
11. Beuth W, Kasprzak H, Wozniak B, Kulwas A, Kotschy M, Rose D, Sniegocki M: Von Willebrand factor in patients with subarachnoid hemorrhage [in Polish]. Neurol Neurochir Pol 35:130-134, 2001.
12. Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA Jr: Identification of an inducible endothelial leukocyte adhesion molecule. Proc Natl Acad Sci U S A 84:9238-9242, 1987.
13. Bonilha L, Marques EL, Carelli EF, Fernandes YB, Cardoso AC, Maldaum MV, Borges G: Risk factors and outcome in 100 patients with aneurysmal subarachnoid hemorrhage. Arq Neuropsiquiatr 59:676-680, 2001.
14. Borel CO, McKee A, Parra A, Haglund MM, Solan A, Prabhakar V, Sheng H, Warner DS, Niklason L: Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage. Stroke 34:427-433, 2003.
15. Botterell EH, Loughheed WM, Scott J, Vandewater SL: Hypothermia, and interruption of carotid, or carotid and vertebral circulation, in the surgical management of intracranial aneurysms. J Neurosurg 13:1-10, 1956.
16. Braughler JM, Hall ED: Central nervous system trauma and stroke: Part 1-Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic Biol Med 6:289-301, 1989.
17. Brouwers PJ, Dippel DW, Vermeiden M, Lindsay KW, Kasan D, van Gijn J: Amount of blood on computed tomography as an independent predictor after aneurysm rupture. Stroke 24:809-814, 1993.
18. Butcher EC: Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 67:1033-1036, 1991.
19. Carmeliet P, Collen D: Vascular development and disorders: Molecular analysis and pathogenic insights. Kidney Int 53:1519-1549, 1998.
20. Cavanagh SJ, Gordon VL: Grading scales used in the management of aneurysmal subarachnoid hemorrhage: A critical review. J Neurosci Nurs 34:288-295, 2002.
21. Charpentier C, Audibert G, Guillemin F, Civit T, Ducrocq X, Bracard S, Hepner H, Picard L, Laxenaire MC: Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage. Stroke 30:1402-1408, 1999.
22. Chiang VL, Claus EB, Awad IA: Toward more rational prediction of outcome in patients with high-grade subarachnoid hemorrhage. Neurosurgery 46:28-35, 2000.
23. Chyatte D, Sundt TM: Cerebral vasospasm after subarachnoid hemorrhage. Mayo Clin Proc 59:498-502, 1984.
24. Claassen J, Bernardini GL, Kreiter K, Bates J, Du YE, Copeland D, Connolly ES Jr, Mayer SA: Effect of asternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: The Fisher scale revisited. Stroke 32:2012-2020, 2001.
25. Claus JJ, Breteler MM, Hasan D, Krenning EP, Bots ML, Grobbee DE, Van Swieten JC, Van Harskamp F, Hofman A: Regional cerebral blood flow and cerebrovascular risk factors in the elderly population. Neurobiol Aging 19:57-64, 1998.
26. Clozel M, Breu V, Burri K, Cassal JM, Fishli W, Gray GA, Hirth G, Loffler BM, Muller M, Neidhart W, Ramuz H: Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 365:759-761, 1993.
27. Clyde BL, Resnick DK, Yonas H, Smith HA, Kaufmann AM: The relationship of blood velocity as measured by transcranial Doppler ultrasonography to cerebral blood flow as determined by stable xenon computed topographic studies after aneurysmal subarachnoid hemorrhage. Neurosurgery 42:510-517, 1998.
28. Compton JS, Redmond S, Simon L: Cerebral blood velocity in subarachnoid hemorrhage: A transcranial Doppler study. J Neurol Neurosurg Psychiatry 50:1499-1503, 1987.
29. Conway JE, Tamargo RJ: Cocaine use is an independent risk factor for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 32:2338-2358, 2001.
30. Crossman J, Bankes M, Bhan A, Crockard HA: The Glasgow Coma Score: Reliable evidence? Injury 29:435-437, 1998.
31. De Micheli E, Pinna G, Alfieri A, Caramia G, Bianchi L, Colivicchi MA, Corte LD, Bricolo A: Post-operative monitoring of cortical taurine in patients with subarachnoid hemorrhage: A microdialysis study. Adv Exp Med Biol 483:621-625, 2000.
32. Dewey RC, Pieper HP, Hunt WE: Experimental cerebral hemodynamics: Vasomotor tone, critical closing pressure, and vascular bed resistance, J Neurosurg 41:597-606, 1974.
33. Dietrich HH, Dacey RG Jr: Molecular keys to the problems of cerebral vasospasm. Neurosurgery 46:517-530, 2000.
34. Domingo Z, Bradley JK, Blamire AM, Brindle K, Styles P, Rajagopalan B: Diffusion weighted imaging and magnetic resonance spectroscopy in a low flow ischemia model due to endothelin induced vasospasm. NMR Biomed 13:154-162, 2000.
35. Dorsch NW: Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr Opin Crit Care 8:128-133, 2002.
36. Drake CG: Management of cerebral aneurysm. Stroke 12:273-283, 1981.
37. Ecker A, Riemenscheider PA: Angiographic demonstration of spasm of the intracranial arteries with special reference to saccular arterial aneurysms. J Neurosurg 8:660-667, 1951.
38. Edvinsson L, Juul R, Jansen I: Perivascular neuropeptides (NPY, VIP, CGRP and SP) in human brain vessels after subarachnoid hemorrhage. Acta Neurol Scand 90:324-330, 1994.
39. Ehrenreich H, Lange M, Near KA, Anneser F, Schoeller LA, Schmid R, Winkler PA, Kehrl JH, Schmiedek P, Goebel FD: Long-term monitoring of immunoreactive endothelin-1 and endothelin-3 in ventricular cerebrospinal fluid, plasma, and 24-h urine of patients with subarachnoid hemorrhage. Res Exp Med (Berl) 192:257-268, 1992.
40. Eldevik OP, Kristiansen K, Torvik A: Subarachnoid hemorrhage and cerebrovascular spasm: Morphological study of intracranial arteries based on animal experiments and human autopsies. J Neurosurg 55:869-876, 1981.
41. Enblad P, Valtysson J, Andersson J, Lilja A, Valind S, Antoni G, Langstrom B, Hillered L, Persson L: Simultaneous intracerebral microdialysis and positron emission tomography in the detection of ischemia in patients with subarachnoid hemorrhage. J Cereb Blood Flow Metab 16:637-644, 1996.
42. Fabender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Schutt S, Fritzinger M, Horn P, Vajkoczy P, Wendall-Wellner M, Ragoschke A, Kuehl S, Brunner J, Schurer L, Schmiedeck P, Hennerici M: Endothelin-1 in subarachnoid hemorrhage: An acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke 31:2971-2975, 2000.
43. Fein JM: Cerebral energy metabolism after subarachnoid hemorrhage. Stroke 6:1-8, 1975.
44. Findlay JM, Macdonald RL, Weir BKA: Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Cerebrovasc Brain Metab Rev 3:336-361, 1991.
45. Findlay JM, Weir BKA, Kanamaru K, Espinosa F: Arterial wall changes in cerebral vasospasm. Neurosurgery 25:736-745, 1989.
46. Finger EB, Bruehl RE, Bainton DF, Springer TA: A differential role for cell shape in neutrophil tethering and rolling on endothelial selectins under flow. J Immunol 157:5085-5096, 1996.
47. Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1-9, 1980.
48. Fletcher TM, Taveras JM, Pool JL: Cerebral vasospasm in angiography for intracranial aneurysms: Incidence and significance in one hundred consecutive angiograms. Arch Neurol 1:38-47, 1959.
49. Flood C, Akinwunmi J, Lagord C, Daniel M, Berry M, Jackowski A, Logan A: Transforming growth factor-β1 in the cerebrospinal fluid of patients with subarachnoid hemorrhage: Titers derived from exogenous and endogenous sources. J Cereb Blood Flow Metab 21:157-162, 2001.
50. Frijns CJ, Rinkel GJ, Castigliego D, van Gijn J, Sixma JJ, Fijnheer R: Endothelial cell activation after subarachnoid hemorrhage. Neurosurgery 50:1223-1229, 2002.
51. Fujimori A, Yanagisawa M, Saito A, Goto K, Masaki T, Mima T, Takakura K, Shigeno T: Endothelin in plasma and cerebrospinal fluid of patients with subarachnoid hemorrhage. Lancet 336:633, 1990.
52. Gaetani P, Tancioni F, Grignani G, Tartara F, Merlo EM, Brocchieri A, Rodriguez-Baena R: Platelet derived growth factor and subarachnoid hemorrhage: A study on asternal cerebrospinal fluid. Acta Neurochir (Wien) 139:319-324, 1997.
53. Glukhova MA, Frid MG, Shekhonin BV, Vasilevskaya TD, Grunwald J, Saginati M, Koteliansky VE: Expression of extradomain A fibronectin sequence in vascular smooth muscle cells is phenotype dependent. J Cell Biol 109:357-366, 1989.
54. Graf CJ, Nibbelink DW: Cooperative study of intracranial aneurysms and subarachnoid hemorrhage. Stroke 5:559-601, 1974.
55. Grosskreutz CL, Anand-Apte B, Quinn TP, Terman BI, Zetter B, D'Amore PA: Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc Res 58:128-136, 1999.
56. Gur D, Good WF, Wolfson SK, Yonas H, Shabason L: In vivo mapping of local cerebral blood flow by xenon-enhanced computed tomography. Science 5:1267-1268, 1982.
57. Gurusinghe NT, Richardson AE: The value of CT in aneurysmal subarachnoid hemorrhage: The concept of a CT score. J Neurosurg 60:763-770, 1984.
58. Haley EC Jr, Kassell NF, Apperson-Hansen C, Maile MH, Alves WM: A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in North America. J Neurosurg 86:467-474, 1997.
59. Haley EC Jr, Kassell NF, Torner JC: The International Cooperative Study on the Timing of Aneurysm Surgery: The North American experience. Stroke 23:205-214, 1992.
60. Hamilton JG, Falconer MA: Immediate and late results of surgery in cases of saccular intracranial aneurysms. J Neurosurg 16:514-541, 1959.
61. Handa Y, Kubota T, Kaneko M, Tsuchida A, Kobayashi H, Kawano H, Kubota T: Expression of intercellular adhesion molecule-1 (ICAM-1) on the cerebral artery following subarachnoid hemorrhage in rats. Acta Neurochir (Wien) 132:92-97, 1995.
62. Hansen-Schwartz JH, Hoel NL, Xu CB, Svendgaard NA, Edvinsson L: Subarachnoid hemorrhage-induced upregulation of the 5-HT1B receptor in cerebral arteries in rats. J Neurosurg 99:115-120, 2003.
63. Haraldsen G, Kvale D, Lien B, Farstad IN, Brandtzaeg P: Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human intestinal microvascular endothelial cells. J Immunol 156:2558-2565, 1996.
64. Hegedus K, Molnar P: Age-related changes in reticulin fibers and other connective tissue elements in the intima of the major intracranial arteries. Clin Neuropathol 8:92-97, 1989.
65. Heros RC, Zervas NT, Negoro M: Cerebral vasospasm. Surg Neurol 5:354-359, 1976.
66. Heros RC, Zervas NT, Varsos V: Cerebral vasospasm after subarachnoid hemorrhage: An update. Ann Neurol 14:599-606, 1983.
67. Hirashima Y, Kurimoto M, Takaba M, Endo S, Takaku A: The use of computed tomography in the prediction of delayed cerebral infarction following acute aneurysm surgery for subarachnoid hemorrhage. Acta Neurochir (Wien) 132:9-13, 1995.
68. Howington JU, Kutz SC, Wilding GE, Awasthi D: Cocaine use as a predictor of outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg 99:271-275, 2003.
69. 2+ in rat brain. Neurosci Lett 109:113-116, 1990.
70. Huber AR, Weiss SJ: Disruption of the subendothelial basement membrane during neutrophil diapedesis in an in vitro construct of a blood vessel wall. J Clin Invest 83:1122-1136, 1989.
71. Inagawa T: Cerebral vasospasm in elderly patients with ruptured intracranial aneurysms. Surg Neurol 36:91-98, 1991.
72. Johsita H, Kassell NF, Sasaki T, Ogawa H: Impaired capillary perfusion and brain edema following experimental subarachnoid hemorrhage: A morphometric study. J Neurosurg 73:410-417, 1990.
73. Juvela S: Plasma endothelin concentrations after aneurysmal subarachnoid hemorrhage. J Neurosurg 92:390-400, 2000.
74. Kamezaki T, Yanaka K, Nagase S, Fujita K, Kato N, Nose T: Increased levels of lipid peroxides as predictive of symptomatic vasospasm and poor outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 97:1302-1305, 2002.
75. Kassell NF, Sasaki T, Colohan AR, Nazar G: Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16:562-572, 1985.
76. Kassell NF, Torner KC, Jane JA, Haley EC Jr, Adams HP: The international cooperative study on the timing of aneurysm surgery: Part II - Surgical results. J Neurosurg 73:37-47, 1990.
77. Kasuya H, Onda H, Kawashima A, Sasahara A, Hori T: Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. Acta Neurochir Suppl (Wien) 77:13-16, 2001.
78. Kasuya H, Shimizu T, Takakura K: Thrombin activity in CSF after SAH is correlated with the degree of SAH, the persistence of subarachnoid clot and the development of vasospasm. Acta Neurochir (Wien) 140:579-584, 1998.
79. Kaufman MJ, Levin JM, Ross MH, Lange N, Rose SL, Kukes TJ, Mendelson JH, Lukas SE, Cohen BM, Renshaw PF: Cocaine-induced cerebral vasoconstriction detected in humans with magnetic resonance angiography. JAMA 279:376-380, 1998.
80. Kishore PR, Rao GU, Fernandez RE, Keenan RL, Arora GD, Gadisseux P, Steward LM, Wist AD, Fatouros PP, Dillard D, Watson CK: Regional cerebral blood flow measurements using stable xenon enhanced computed tomography: A theoretical and experimental evaluation. J Comput Assist Tomogr 8:619-630, 1984.
81. Kitazawa K, Tada T: Elevation of transforming growth factor-β1 levels in cerebral spinal fluid of patients with communicating hydrocephalus after subarachnoid hemorrhage. Stroke 25:1400-1404, 1994.
82. Kitler JP, Crowell RM, Davis KR, Heros RC, Ojemann RG, Zervas T, Fisher CM: The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by CT scan: A prospective study. Neurology 33:424-436, 1983.
83. Kodama N, Mizoi K, Sakurai Y, Suzuki J: Incidence and onset of vasospasm, in Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore, Williams & Wilkins, 1980, pp 284-286.
84. Kodama N, Sasaki T, Kawakami M, Sato M, Asari J: Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage: Outcome in 217 patients. Surg Neurol 53:110-118, 2000.
85. Kuhl D, Barrio J, Huang S, Selin C, Ackermann, Lear JL, Wy JE, Lin TH, Phelps ME: Quantifying local cerebral blood flow in N-isopropyl-p-I-123- iodoamphetamine (IMP) tomography. J Nucl Med 23:196-203, 1982.
86. Laher I, Zhang JH: Protein kinase C and cerebral vasospasm. J Cereb Blood Flow Metab 21:887-906, 2001.
87. Lanzino G, Kassell NF, Germanson TP, Kongable GL, Truskowski LL, Torner JC, Jane JA: Age and outcome after aneurysmal subarachnoid hemorrhage: Why do older patients fare worse? J Neurosurg 85:410-418, 1996.
88. Lasner TM, Weil RJ, Riina HA, King JT Jr, Zager EL, Raps EC, Flamm ES: Cigarette smoking-induced increase in the risk of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 87:381-384, 1997.
89. Laumer R, Steinmeier R, Gonner F, Vogtmann T, Priem R, Fahlbusch R: Cerebral hemodynamics in subarachnoid hemorrhage evaluated by transcranial Doppler sonography: Part I - Reliability of flow velocities in clinical management. Neurosurgery 33:1-9, 1993.
90. Leclerc X, Fichten A, Gauvrit JY, Riegel B, Steinling M, Lejeune JP, Pruvo JP: Symptomatic vasospasm after subarachnoid hemorrhage: Assessment of brain damage by diffusion and perfusion-weighted MRI and single-photon emission computed tomography. Neuroradiology 44:610-614, 2002.
91. Le Roux PD, Elliott JP, Eskridge JM, Cohen W, Winn HR: Risks and benefits of diagnostic angiography after aneurysm surgery: A retrospective analysis of 597 studies. Neurosurgery 42:1248-1254, 1998.
92. Lewis DH, Eskridge JM, Newell DW, Grady MS, Cohen WA, Dalley RW, Loyd D, Grothaus-King A, Young P, Winn HR: Brain SPECT and the effect of cerebral angioplasty in delayed ischemia due to vasospasm. J Nucl Med 33:1789-1796, 1992.
93. Lindegaard KF, Nornes H, Bakke SJ, Sorteberg W, Nakstad P: Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements. Acta Neurochir (Wien) 100:12-24, 1989.
94. Lowry VW, Stanley KK, Stocker R: High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc Natl Acad Sci U S A 89:10316-10320, 1992.
95. Luscher TF, Tanner FC: Endothelial regulation of vascular tone and growth. Am J Hypertens 6[Suppl 7]:S283-S293, 1993.
96. Lysakowski C, Walder B, Costanza MC, Tramer MR: Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: A systematic review. Stroke 32:2292-2298, 2001.
97. Macdonald RL: Pathophysiology and molecular genetics of vasospasm. Acta Neurochir Suppl (Wien) 77:7-11, 2001.
98. Macdonald RL, Weir BKA: A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22:971-982, 1991.
99. Macdonald RL, Rosengart A, Huo D, Karrison T: Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage. J Neurosurg 99:644-652, 2003.
100. Mack WJ, Mocco J, Hoh DJ, Huang J, Choudhri TF, Kreiter KT, Lozier A, Opperman M, Poisik A, Yorgason J, Solomon RA, Mayer SA, Connolly ES Jr: Outcome prediction with serum intercellular adhesion molecule-1 levels after aneurysmal subarachnoid hemorrhage. J Neurosurg 96:71-75, 2002.
101. Madden JA, Powers RH: Effect of cocaine and cocaine metabolites on cerebral arteries in vitro. Life Sci 47:1109-1114, 1990.
102. Madden JA, Konkol RJ, Keller PA, Alvarez TA: Cocaine and benzoylecgonine constrict cerebral arteries by different mechanisms. Life Sci 56:679-686, 1995.
103. Maiuri F, Gallicchio B, Donati P, Carandente M: The blood leukocyte count and its prognostic significance in subarachnoid hemorrhage. J Neurosurg Sci 31:45-48, 1987.
104. Masaoka H, Suzuki R, Hirata Y, Emori T, Marumo F, Hirakawa K: Raised plasma endothelin in aneurysmal subarachnoid hemorrhage. Lancet 2:1402, 1989.
105. Mayberg MR, Batjer HH, Dacey RG Jr, Diringer M, Haley EC Jr, Heros RC, Sternau LL, Torner J, Adams HP Jr, Feinberg W, Thies W: Guidelines for the management of aneurysmal subarachnoid hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation 90:2592-2605, 1990.
106. Mayberg MR, Okada T, Bark DH: Morphologic changes in cerebral arteries after subarachnoid hemorrhage. Neurosurg Clin N Am 1:417-429, 1990.
107. McGirt MJ, Lynch JR, Blessing R, Warner DS, Friedman AH, Laskowitz DT: Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 51:1128-1134, 2002.
108. McGirt MJ, Mavropoulos JC, McGirt LY, Alexander MJ, Friedman AH, Laskowitz DT, Lynch JR: Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 98:1222-1226, 2003.
109. Melder RJ, Koenig GC, Witwer BP, Safabakhsh N, Munn LL, Jain RK: During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med 2:992-997, 1996.
110. Meyer JS, Hayman LH, Yamamoto M, Sakal F, Nakajima S: Local cerebral blood flow measured by CT after stable xenon inhalation. AJR Am J Roentgenol 135:239-251, 1980.
111. Meyer JS, Terayama Y, Takashima S: Cerebral circulation in the elderly. Cerebrovasc Brain Metab Rev 5:122-146, 1993.
112. Miyazawa T, Suzuki T, Fujimoto K, Kaneda T: Phospholipid hydroperoxide accumulation in liver of rats intoxicated with carbon tetrachloride and its inhibition by dietary α-tocopherol. J Biochem 107:689-693, 1990.
113. Mocco J, Mack WJ, Kim GH, Lozier AP, Laufer I, Kreiter KT, Sciacca RR, Solomon RA, Mayer SA, Connolly ES Jr: Rise in serum soluble intercellular adhesion molecule-1 levels with vasospasm following subarachnoid hemorrhage. J Neurosurg 97:537-541, 2002.
114. Mohsen F, Pomonis S, Illingworth R: Prediction of delayed cerebral ischemia after subarachnoid hemorrhage by computed tomography. J Neurol Neurosurg Psychiatry 47:1197-1202, 1984.
115. Mori K, Nakajima K, Maeda M: Long-term monitoring of CSF lactate levels and lactate/pyruvate ratios following subarachnoid hemorrhage. Acta Neurochir (Wien) 125:20-26, 1993.
116. Naderi S, Ozguven A, Bayhan H, Gokalp H, Erdogan A, Egemen N: Evaluation of cerebral vasospasm in patients with subarachnoid hemorrhage using single photon emission computed tomography. Neurosurg Rev 17:261-265, 1994.
117. Nam DH, Kim JS, Hong SC, Lee WH, Lee JI, Shin HJ, Park K, Eoh W, Han DH, Kim JH: Expression of interleukin-1β in lipopolysaccharide stimulated monocytes derived from patients with aneurysmal subarachnoid hemorrhage is correlated with cerebral vasospasm. Neurosci Lett 312:41-44, 2001.
118. Nash MC, Wade AM, Shah V, Dillon MJ: Normal levels of soluble E-selectin, soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular cell adhesion molecule-1 (VCAM-1) decrease with age. Clin Exp Immunol 103:167-170, 1996.
119. Nayler W: Endothelin: Isoforms, binding sites and possible implications in pathology. Trends Pharmacol Sci 11:96-99, 1990.
120. Neil-Dwyer G, Cruickshank J: The blood leukocyte count and its prognostic significance in subarachnoid hemorrhage. Brain 97:79-86, 1974.
121. Nicosia RF, Bonanno E, Smith M: Fibronectin promotes the elongation of microvessels during angiogenesis in vitro. J Cell Physiol 154:654-661, 1993.
122. Niikawa S, Hara S, Ohe N, Miwa Y, Ohkuma A: Correlation between blood parameters and symptomatic vasospasm in subarachnoid hemorrhage patients. Neurol Med Chir (Tokyo) 37:881-885, 1997.
123. Niizuma H, Kwak R, Ohi T, Katakura R, Mizoi K, Suzuki J: Angiographical study of cerebral vasospasm following rupture of intracranial aneurysm (2nd report): Relation between the site of aneurysm and the occurrence of the vasospasm [in Japanese]. No Skinkei Geka 6:863-869, 1978.
124. Nilsson OG, Brandt L, Ungerstedt U, Säveland H: Bedside detection of brain ischemia using intracerebral microdialysis: Subarachnoid hemorrhage and delayed ischemic deterioration. Neurosurgery 45:1176-1184, 1999.
125. Nishioka H, Torner JC, Graf CJ, Kassels NF, Sahs AL, Goettler LC: Cooperative Study of Intracranial Aneurysms and Subarachnoid Hemorrhage: A long-term prognostic study-Part II: Ruptured intracranial aneurysms managed conservatively. Arch Neurol 41:1142-1146, 1984.
126. Ohkuma H, Parney I, Megyesi J, Ghahary A, Findlay JM: Antisense preproendothelin-oligoDNA therapy for vasospasms in a canine model of subarachnoid hemorrhage. J Neurosurg 90:1105-1114, 1999.
127. Ohkuma H, Tsurutani H, Suzuki S: Changes of β-actin mRNA expression in canine vasospastic basilar artery after experimental subarachnoid hemorrhage. Neurosci Lett 311:9-12, 2001.
128. Ohman J, Servo A, Heiskanen O: Risk factors for cerebral infarction in good-grade patients after Subarachnoid hemorrhage and surgery: A prospective study. J Neurosurg 74:14-20, 1991.
129. Okada Y, Shima T, Nishida M, Yamane K, Hatayama T, Yamanaka C, Yoshida A: Comparison of transcranial Doppler investigation of aneurysmal vasospasm with digital subtraction angiographie and clinical findings. Neurosurgery 45:443-450, 1999.
130. O'Leary DH, Hill TC, Lee RG, Clouse ME, Holman BL: The use of 123-iodoamphetamines and single photon emission computed tomography to assess local cerebral blood flow. AJNR Am J Neuroradiol 4:547-549, 1983.
131. Onda H, Kasuya H, Takakura K, Hori T, Imaizumi TA, Takeuchi T, Inoue H, Takeda J: Indentification of genes differentially expressed in canine vasospastic arteries after subarachnoid hemorrhage. J Cereb Blood Flow and Metab 19:1279-1288, 1999.
132. Oshiro EM, Walter KA, Piantadosi S, Witham TF, Tamargo RJ: A new subarachnoid hemorrhage grading system based on the Glasgow Coma Scale: A comparison with the Hunt and Hess and World Federation of Neurological Surgeons Scales in a clinical series. Neurosurgery 41:140-147, 1997.
133. Ostergaard JR: Risk factors in intracranial saccular aneurysms: Aspects on the formation and rupture of aneurysms, and development of cerebral vasospasm. Acta Neurol Scand 80:81-98, 1989.
134. Parkinson D, Stephensen S: Leukocytosis and subarachnoid hemorrhage. Surg Neurol 21:132-134, 1984.
135. Paschen W: Role of calcium in neuronal cell injury: Which subcellular compartment is involved? Brain Res Bull 53:409-413, 2000.
136. Peerless SJ, Fox AJ, Komatsu K, Hunter IG: Angiographic study of vasospasm following subarachnoid hemorrhage in monkeys. Stroke 13:473-479, 1982.
137. Persson L, Valtysson J, Enblad P, Warme PE, Cesarini K, Lewen A, Hillered L: Neurochemical monitoring using intracerebral microdialysis in patients with subarachnoid hemorrhage. J Neurosurg 84:606-616, 1996.
138. Pitts LH, Macpherson P, Wyper DJ, Jennett B, Blair I, Cooke MB: Effects of vasospasm on cerebral blood flow after subarachnoid hemorrhage, in Wilkins RH (ed): Cerebral Arterial Spasm: Proceedings of the Second International Workshop. Baltimore, Williams & Wilkins, 1980, pp 314-319.
139. Pluta RM, Boock RJ, Afshar JK, Clouse K, Bacic M, Ehrenreich H, Oldfield EH: Source and cause of endothelin-1 release into cerebral spinal fluid after subarachnoid hemorrhage. J Neurosurg 87:287-293, 1997.
140. Polidori MC, Frei B, Rordorf G, Ogilvy CS, Koroshetz WJ, Beal MF: Increased levels of plasma cholesteryl ester hydroperoxides in patients with subarachnoid hemorrhage. Free Radic Biol Med 23:762-767, 1997.
141. Polin RS, Bavbek M, Shaffrey ME, Billups K, Bogaev CA, Kassell NF, Lee KS: Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebral spinal fluid of patients after subarachnoid hemorrhage. J Neurosurg 89:559-567, 1998.
142. Polverini PJ: Cellular adhesion molecules: Newly identified mediators of angiogenesis. Am J Pathol 148:1023-1029, 1996.
143. Powsner RA, O'Tuama LA, Jabre A, Melhem ER: SPECT imaging in cerebral vasospasm following subarachnoid hemorrhage. J Nucl Med 39:765-769, 1998.
144. Purdy PD: Imaging cerebral blood flow in interventional neuroradiology: Choice of technique and indications. AJNR Am J Neuroradiol 12:424-427, 1991 (comment).
145. Rabb CH, Tang G, Chin LS: A statistical analysis of factors related to symptomatic cerebral vasospasm. Acta Neurochir (Wien) 127:27-31, 1994.
146. Raines EW, Ross R: Platelet-derived growth factor in vivo, in Westermark B, Sorg C (eds): Biology of Platelet-derived Growth Factor. Basel, Karger, 1993.
147. Ramamoorthy C, Sharar SR, Harlan JM, Tedder TF, Winn RK: Blocking L-selectin function attenuates reperfusion injury following hemorrhagic shock in rabbits. Am J Physiol 271[Suppl 5]:H1871-H1877, 1996.
148. Rordorf G, Koroshetz WJ, Copen WA, Gonzalez G, Yamada K, Schaefer PW, Schwamm LH, Ogilvy CS, Sorensen AG: Diffusion- and perfusion-weighted imaging in vasospasm after subarachnoid hemorrhage. Stroke 30:599-605, 1999.
149. Rosen J, Butala A, Oropello J, Sacher M, Rudolph SH, Goldsmith SJ, Holan V, Stritzke P: Postoperative changes on brain SPECT imaging after aneurysmal subarachnoid hemorrhage. Clin Nucl Med 19:595-597, 1994.
150. Rowe J, Blamire AM, Domingo Z, Moody V, Molyneux A, Byrne J, Cadoux-Hudsen T, Rada G: Discrepancies between cerebral perfusion and metabolism after subarachnoid hemorrhage: A magnetic resonance approach. J Neurol Neurosurg Psychiatry 64:98-103, 1998.
151. Ryba M, Jarzabek-Chorzelska M, Chorzelski T, Pastuszko M: Is vascular angiography following intracranial aneurysm rupture immunologically mediated? Acta Neurochir (Wien) 117:34-37, 1992.
152. Saito I, Sano K: Vasospasm following rupture of cerebral aneurysms. Neurol Med Chir (Tokyo) 19:103-107, 1979.
153. Sano K, Asano T, Tanishima T, Sasaki T: Lipid peroxidation as a cause of cerebral vasospasm. Neurol Res 2:253-272, 1980.
154. Sarrafzadeh A, Haux D, Sakowitz O, Benndorf G, Herzog H, Kuechler I, Unterberg A: Acute focal neurological deficits in aneurysmal subarachnoid hemorrhage: Relation of clinical course, CT findings, and metabolite abnormalities monitored with bedside microdialysis. Stroke 34:1382-1388, 2003.
155. Säveland H, Nilsson OG, Boris-Moller MF, Wieloch T, Brandt L: Intracerebral microdialysis of glutamate and aspartate in two vascular territories after aneurysmal subarachnoid hemorrhage. Neurosurgery 38:12-19, 1996.
156. Seiffert V, Loftler BM, Zimmermann M, Roux S, Stolke D: Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage: Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. J Neurosurg 82:55-62, 1995.
157. Seiler RW, Grolimund P, Aaslid R, Huber P, Nornes H: Cerebral vasospasm evaluated by transcranial ultrasound correlated with clinical grade and CT-visualized subarachnoid hemorrhage. J Neurosurg 64:594-600, 1986.
158. Sekhar LM, Wechsler LR, Yonas H, Luyckx K, Obrist W: Value of transcranial Doppler examination in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 22:813-821, 1988.
159. Sercombe R, Tran Dinh YR, Gomis P: Cerebrovascular inflammation following subarachnoid hemorrhage. Jpn J Pharmacol 88:227-249, 2002.
160. Shigeno T, Mima T, Yanagisawa M, Saito A, Goto K, Yamashita K, Takenouchi T, Matsuura N, Yamasaki Y, Yamada K, Masaki T, Takakura K: Possible role of endothelin in the pathogenesis of cerebral vasospasm. J Cardiovasc Pharmacol 17[Suppl 7]:S480-S483, 1991.
161. Shimoda M, Yamada S, Yamamoto Y, Tsugane R, Sato O: Time course of CSF lactate level in subarachnoid hemorrhage. Acta Neurochir (Wien) 99:127-134, 1989.
162. Sills AK Jr, Clatterbuck RE, Thompson RC, Cohen PL, Tamargo RJ: Endothelial cell expression of intercellular adhesion molecule 1 in experimental posthemorrhagic vasospasm. Neurosurgery 41:453-461, 1997.
163. Sloan MA, Haley EC, Kassell NF, Henry ML, Stewart SR, Beskin RR, Sevilla EA, Torner JC: Sensitivity and specificity of transcranial Doppler
164. Smith TP, Enterline DS: Endovascular treatment of cerebral vasospasm. J Vasc Interv Radiol 11:547-559, 2000.
165. Smith RR, Glower BR, Grotendorst GM, Yabuno N, Cruse JM: Arterial wall changes in early human vasospasm. Neurosurgery 16:171-176, 1985.
166. Song JK, Elliott JP, Eskridge JM: Neuroradiologic diagnosis and treatment of vasospasm. Neuroimaging Clin N Am 7:819-835, 1997.
167. Spallone A, Acqui M, Pastore FS, Guidetti B: Relationship between leukocytosis and ischemic complications following aneurysmal subarachnoid hemorrhage. Surg Neurol 27:253-258, 1987.
168. Strickland TL, Mena I, Villanueva-Meyer J, Miller BL, Cummings J, Mehringer CM, Satz P, Myers H: Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci 5:419-427, 1993.
169. Sugi T, Fujishima M, Omae T: Lactate and pyruvate concentrations, and acid-base balance of cerebral spinal fluid in experimentally induced intracerebral and subarachnoid hemorrhage in dogs. Stroke 6:715-719, 1975.
170. Suzuki H, Kanamaru K, Kuroki M, Sun H, Waga S, Miyazawa T: Effects of trilizad mesylate on vasospasm and phospholipid hydroperoxides in a primate model of subarachnoid hemorrhage. Stroke 30:450-456, 1999.
171. Suzuki R, Masaoka H, Hirata Y, Marumo F, Isotani E, Hirakawa K: The role of endothelin-1 in the origin of cerebral vasospasm in patients with subarachnoid hemorrhage. J Neurosurg 77:96-100, 1992.
172. Suzuki H, Soto S, Suzuki Y, Oka M, Tsuchiya, Iino I, Yamanaka T, Ishihara N, Shumoda S: Endothelin immunoreactivity on cerebrospinal fluid of patients with subarachnoid hemorrhage. Ann Med 22:233-236, 1990.
173. Takasaki I, Chobanian AV, Mamuya WS, Brecher P: Hypertension induces alternatively spliced forms of fibronectin in rat aorta. Hypertension 20:20-25, 1992.
174. Tanaka T, Nishimura Y, Tsunoda H, Naka M: Pharmacogenomics and therapeutic target validation in cerebral vasospasm. J Cardiovasc Pharmacol 36[Suppl 2]:S1-S4, 2000.
175. Tanoi C, Suzuki Y, Shibuya M, Sugita K, Masuzawa K, Asano M: Mechanisms of enhanced vasoconstrictor responses to endothelin-1 in canine cerebral arteries. J Cereb Blood Flow Metab 11:371-379, 1991.
176. Torbey MT, Hauser TK, Bhardwaj A, Williams MA, Ulatowski JA, Mirski MA, Razumovsky AY: Effect of age on cerebral blood flow velocity and incidence of vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 32:1-14, 2001.
177. Torner JC, Kassels NF, Wallace RB, Adams HP: Preoperative prognostic factors for rebleeding and survival in aneurysm patients receiving antifibrinolytic therapy: Report on Cooperative Aneurysm Study. Neurosurgery 9:506-513, 1981.
178. Tran Dinh YR, Debdi M, Couraud JY, Creminon C, Seylaz J, Sercombe R: Time course of variations in rabbit cerebrospinal fluid levels of calcitonin gene-related peptide- and substance P-like immunoreactivity in experimental subarachnoid hemorrhage. Stroke 25:160-164, 1994.
179. Treggiari-Venzi MM, Suter PM, Romand JA: Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: A problem of neurointensive care. Neurosurgery 48:249-262, 2001.
180. U.S. Department of Health and Human Services: Detailed Diagnosis and Procedures, National Hospital Discharge Survey, 1990. Hyattsville, U.S. Department of Health and Human Services, 1992, DHHS Publication PHS 92-1774, Series 13.
181. van den Bergh WM, Algra A, van der Sprenkel JW, Tulleken CA, Rinke GJ: Hypomagnesemia after aneurysmal subarachnoid hemorrhage. Neurosurgery 52:276-282, 2003.
182. van Mourik JA, Boertjes R, Huisveld IA, Fijnvandraat K, Pajkrt D, van Genderen PJ, Fijnheer R: Von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbation. Blood 94:179-185, 1999.
183. Volkow ND, Mullani N, Gould KL, Adler S, Krajewski K: Cerebral blood flow in chronic cocaine users: A study with positron emission tomography. Br J Psychiatry 152:641-648, 1988.
184. + feeding in stroke prone hypertensive rats. Hypertension 15:318-326, 1990.
185. Vora YY, Suarez-Almazor M, Steinke DE, Martin ML, Findlay JM: Role of transcranial Doppler monitoring in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 44:1237-1248, 1999.
186. Weir BKA, Disney L, Grace M, Roberts P: Daily trends in white blood cell count and temperature after subarachnoid hemorrhage from aneurysm. Neurosurgery 25:161-165, 1989.
187. Weir BKA, Kongable GL, Kassell NF, Schultz JR, Truskowski LL, Sigres A: Cigarette smoking as a cause of aneurysmal subarachnoid hemorrhage and risk for vasospasm: A report of the Cooperative Aneurysm Study. J Neurosurg 89:405-411, 1998.
188. Weir BKA, Macdonald RL, Stoodley M: Etiology of cerebral vasospasm. Acta Neurochir (Wien) 72:27-46, 1999.
189. Wilkins RH, Alexander JA, Odom GL: Intracranial arterial spasm: A clinical analysis. J Neurosurg 29:121-134, 1968.
190. Winn HR, Almaani WS, Berga SL, Jane JA, Richardson AE: The long-term outcome in patients with multiple aneurysms: Incidence of late hemorrhage and implications for treatment of incidental aneurysms. J Neurosurg 59:642-651, 1983.
191. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415, 1988.
192. Yanaka K, Kamezaki T, Fujita K, Kato N, Nagase S, Hirayama A, Asakawa H, Yamazaki T, Nose T: Prevention of delayed cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Drugs Today 37:573-578, 2001.
193. Yonas H, Gur D, Classen D, Wolfson SK, Moossy J: Stable xenon enhanced computer tomography in the study of clinical and pathologic correlates of focal ischemia in baboons. Stroke 19:228-238, 1988.
194. Zabramski JM, Spetzler RF, Bonstelle C: Chronic cerebral vasospasm: Effect of volume and timing of hemorrhage in a canine model. Neurosurgery 18:1-6, 1986.
195. Zempo N, Koyama N, Kenagy RD, Lea HJ, Clowes AW: Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vasc Biol 16:28-33, 1996.
196. Zimmermann M: Endothelin in cerebral vasospasm: Clinical and experimental results. J Neurosurg Sci 41:139-151, 1997.
197. Zubkov AY, Rollins KS, Parent AD, Zhang J, Bryan RM: Mechanism of endothelin-1-induced contraction in rabbit basilar artery. Stroke 31:526-533, 2000.
198. Zuccarello M, Boccaletti R, Roman A, Rapoport RM: Endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 29:1924-1929, 1998.